-transparent.png){kind=logo}
The lantibiotics are a group of ribosomally synthesised, post-translationally modified peptides containing unusual amino acids, such as dehydrated and lanthionine residues. This group of bacteriocins has attracted much attention in recent years due to the success of the well characterised lantibiotic, nisin, as a food preservative. Numerous other lantibiotics have since been identified and can be divided into two groups on the basis of their structures, designated type-A and type-B. To date, many of these lantibiotics have undergone extensive characterisation resulting in an advanced understanding of them at both the structural and mechanistic level. This review outlines some of the more recent developments in the biochemistry, genetics and mechanism of action of these peptides.
O McAuliffe, and
R P Ross, and
C Hill
February 2005,
Chemical reviews,
O McAuliffe, and
R P Ross, and
C Hill
January 2009,
Current pharmaceutical biotechnology,
O McAuliffe, and
R P Ross, and
C Hill
October 1999,
Natural product reports,
O McAuliffe, and
R P Ross, and
C Hill
May 2005,
International journal of food microbiology,
O McAuliffe, and
R P Ross, and
C Hill
April 2006,
Antimicrobial agents and chemotherapy,
O McAuliffe, and
R P Ross, and
C Hill
November 2014,
Applied and environmental microbiology,
O McAuliffe, and
R P Ross, and
C Hill
February 2005,
Chemical reviews,
O McAuliffe, and
R P Ross, and
C Hill
January 1982,
Advances in protein chemistry,
O McAuliffe, and
R P Ross, and
C Hill
February 1996,
Antonie van Leeuwenhoek,
O McAuliffe, and
R P Ross, and
C Hill
November 2006,
Applied microbiology and biotechnology,
